Hyperlipidemia: Clinical Trials

7 trials for Hyperlipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Unknown 7
Phase 23Unknown 3

Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg, Amlodipine 10mg+Valsartan 160mg, Valsartan 160mg+Atorvastatin 40mg - Hypertension, Hyperlipidemia
Phase 3UnknownHK inno.N Corporation1802017-10-132018-08-21
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Rosuvastatin, Atorvastatin - Hyperlipidemia
Phase 2 / Phase 3UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh902016-09-012016-12-02
Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Telmisartan 80mg, Rosuvastatin 20mg, Rosuvastatin 10mg - Hypertension, Hyperlipidemia
Phase 3UnknownIlDong Pharmaceutical Co Ltd3102013-05-012014-03-14
Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids
Kochujang Pills, Placebo - Hyperlipidemia
Phase 2 / Phase 3UnknownChonbuk National University Hospital602012-11-012012-11-29
The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides
EGCG(Epigallocatechin Gallate), Placebo - Diabetes Mellitus, Hyperlipidemia
Phase 2 / Phase 3UnknownTaipei City Hospital922012-05-012014-05-26
Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Pitavastatin, Atorvastatin - Hyperlipidemia
Phase 3UnknownTai Tien Pharmaceuticals Co., Ltd.2002011-07-012011-07-01
The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles
Lipid-lowing Tea - Hyperlipidemia
Phase 3UnknownChina Medical University Hospital2006-11-07

Narrower conditions

Hyperlipidemias (7)  ·  Hypertension (2)  ·  Diabetes Mellitus (1)

Broader conditions

Dyslipidemias (7)  ·  Lipid Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)

Interventions

Atorvastatin (3)  ·  Rosuvastatin Calcium (2)  ·  Amlodipine (1)  ·  Cellulose (1)  ·  Tea (1)  ·  Telmisartan (1)  ·  Valsartan (1)  ·  pitavastatin (1)

Sponsors

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  China Medical University Hospital (1)  ·  Chonbuk National University Hospital (1)  ·  HK inno.N Corporation (1)  ·  IlDong Pharmaceutical Co Ltd (1)  ·  Tai Tien Pharmaceuticals Co., Ltd. (1)  ·  Taipei City Hospital (1)

Countries

South Korea (3)  ·  Taiwan (3)  ·  Bangladesh (1)

Top investigators

Chia-I Tsai, V.S (1)  ·  Chung-Hua Hsu, PHD (1)  ·  Duk-Hyun Kang, Ph.D (1)  ·  Jaw-Wen Chen, M.D. Ph.D. (1)  ·  Samia Tonu, MBBS (1)

Results publications

PMID 18468736, PMID 24098467, PMID 25027585, PMID 26093535